Investor Relations

MYGN: 1Q23
Earnings Call

May 3 at 4:30pm ET

Register to watch Download presentation
Investor Relations

MYGN: 1Q23
Earnings Call

May 3 at 4:30pm ET

Register to watch Download presentation

Events & Presentations

View all events

Financial Reports and Filings

Date Filing Title Downloads
06/02/2023 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing RTF XLS PDF HTML XBRL
06/01/2023 S-8 Securities offered to employees pursuant to employee benefit plans RTF XLS PDF HTML XBRL
05/04/2023 10-Q Quarterly report which provides a continuing view of a company's financial position RTF XLS PDF HTML XBRL
05/03/2023 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
04/17/2023 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
04/17/2023 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
04/12/2023 ARS An annual report to security holders RTF XLS PDF HTML XBRL
04/12/2023 DEF 14A Official notification to shareholders of matters to be brought to a vote ("Proxy") RTF XLS PDF HTML XBRL
04/12/2023 DEFA14A Additional proxy soliciting materials - definitive RTF XLS PDF HTML XBRL
03/30/2023 PRE 14A A preliminary proxy statement providing notification matters to be brought to a vote RTF XLS PDF HTML XBRL
View all filings

Latest News

Myriad Genetics Highlights Latest Oncology Portfolio Advancements and New Data at ASCO 2023 Thumbnail

Myriad Genetics Highlights Latest Oncology Portfolio Advancements and New Data at ASCO 2023

Jun 01, 2023 | Products | Corporate

Read more
Adam Brufsky, MD, PhD, FACP Named Oncology Scientific Advisor to Myriad Genetics Thumbnail

Adam Brufsky, MD, PhD, FACP Named Oncology Scientific Advisor to Myriad Genetics

May 31, 2023 | Corporate

Read more
Myriad Genetics Adds Folate Receptor Alpha to Precise™ Oncology Solutions Portfolio to Expand Treatment Options for Women Living with Ovarian Cancer Thumbnail

Myriad Genetics Adds Folate Receptor Alpha to Precise™ Oncology Solutions Portfolio to Expand Treatment Options for Women Living with Ovarian Cancer

May 24, 2023 | Products

Read more
View all news releases